Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Ryan Peña

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Archives of Pathology & Laboratory Medicine|February 16, 2022
Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive TransfusionsJensyn Cone Sullivan, Jeremy Ryan Peña
Transfusion|April 18, 2018
Peripartum management of HLA alloimmune platelet refractorinessJeremy Ryan Peña, Leanna Sudhof, Barbara O'Brien
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2013
Complement-dependent cytotoxicity crossmatchJeremy Ryan Peña, Donna Fitzpatrick, Susan L Saidman
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Archives of Pathology & Laboratory Medicine|February 16, 2022
Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive TransfusionsJensyn Cone Sullivan, Jeremy Ryan Peña
Transfusion|April 18, 2018
Peripartum management of HLA alloimmune platelet refractorinessJeremy Ryan Peña, Leanna Sudhof, Barbara O'Brien
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2013
Complement-dependent cytotoxicity crossmatchJeremy Ryan Peña, Donna Fitzpatrick, Susan L Saidman
Pageof 1